|

Floxuridine Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: 2'-Deoxy-5-fluorouridine, 5-FUdR, 5-Fluoro-2'-deoxyuridine, 5-Fluorodeoxyuridine, 5-Fluorouracil deoxyriboside +8 more

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Oslo University Hospital1
  • National Cancer Institute (NCI)1
  • ECOG-ACRIN Cancer Research Group1

Indications

  • Cancer3
  • Liver Disease2
  • Liver Cancer2
  • Adrenal Cortex Neoplasms1
  • Adrenal Gland Neoplasms1

Other1 trial

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
Phase 2

Birmingham, Alabama1 trial

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

University of Alabama at Birmingham Cancer Center

Phase 3

Bethesda, Maryland1 trial

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Institutes of Health Clinical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.